<DOC>
	<DOCNO>NCT02960126</DOCNO>
	<brief_summary>This study design order evaluate compare efficacy safety aspirin clopidogrel patient low stroke risk Atrial Fibrillation ( AF ) .</brief_summary>
	<brief_title>Efficacy Safety Aspirin Clopidogrel Atrial Fibrillation With Low Moderate Stroke Risk</brief_title>
	<detailed_description>Efficacy outcome evaluate major cerebro-cardiovascular event include stroke , cardiovascular death , myocardial infarction 1 year-medication period . In addition , safety outcome evaluate gastrointestinal response include peptic ulcer upper gastrointestinal bleeding event study drug repeat gastroenteroscopic examination medication GI specialist .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>1 . Man Women &gt; 20 year old 2. newly detect AF ( CHA2DS2VASc index score : 1 ) 3 . Patient need antiplatelet therapy use aspirin clopidogrel stroke prevention 4. volunteer 5. childbearing age woman take proper oral contraceptive 1 . No specific contraindication history hypersensitivity Clopidogrel aspirin 2 . Patient active GI bleeding bleeding tendency major bleed history 3. less 1 year residual expect life 4 . Pregnant breastfeed woman 5 . Other cause , determine charge physician 6 . Patient definite GERD need special treatment 7 . Patient need take NSAID ( NonSteroidal AntiInflammatory Drug ) 2 week</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>